About Fulvestrant Injection
Discover the new release-FULVIRA Fulvestrant Injection 50mg/ml, a magnificent offer for hospitals specializing in hormone receptor-positive advanced breast cancer. This reduced-price package, available exclusively via prescription, reflects an uncommon dedication to quality medicine grade. Each valiant dose delivers potent anti-cancer benefits through intramuscular administration, ensuring optimal results for adult female patients. Packaged in white and blue vials (2x5mL per box), FULVIRA features clear English and Hindi labeling, and is recommended for professional use. Secure your supply from India's trusted exporter, supplier, and trader today.
Diverse Medical & Commercial Applications of Fulvestrant Injection
FULVIRA Fulvestrant Injection stands out for its uncommon estrogen receptor antagonist capabilities, administered intramuscularly. While commonly indicated for advanced breast cancer in adult females, its use in clinical research settings and specialized oncology units highlights its broader value in medicine grade applications. Only administered by professionals, its liquid formula ensures safe, targeted delivery directly to the affected tissue, reinforcing its reputation as a valuable commercial pharmaceutical solution for hospital settings.
Market Reach, Certifications, and Logistics of Fulvestrant Injection
FULVIRA Fulvestrant Injection has a valiant presence in India's main domestic market, with meticulous packaging and certification adhering to medical export standards. Each box is dispatched with precision logistics, safeguarding the quality of contents. The vials are packaged securely in a white and blue box, labeled in English and Hindi for accessibility. Careful attention to expiry dating and storage below 25C ensures product integrity from supplier to hospital shelf.
FAQ's of Fulvestrant Injection:
Q: How is FULVIRA Fulvestrant Injection administered?
A: FULVIRA is administered via intramuscular injection, typically by a healthcare professional within a hospital setting. The recommended dosage is 50mg per mL, as directed by a physician.
Q: What are the main indications for using Fulvestrant Injection?
A: FULVIRA is specifically indicated for the treatment of hormone receptor positive advanced breast cancer in adult female patients. It functions as an estrogen receptor antagonist to help manage cancer progression.
Q: When should Fulvestrant Injection be used?
A: Fulvestrant Injection should be used under a physician's guidance, typically when hormone receptor positive advanced breast cancer is diagnosed in female adults and after consideration of treatment options.
Q: Where can I purchase FULVIRA Fulvestrant Injection?
A: FULVIRA Fulvestrant Injection is available from certified exporters, suppliers, and traders in India, usually distributed to hospitals and healthcare facilities.
Q: What is the process for storage and handling of this product?
A: Store FULVIRA Fulvestrant Injection below 25C, following packaging instructions. Check the expiry date on the pack and ensure it is handled by qualified medical professionals.
Q: What benefits does this injection offer compared to alternative therapies?
A: FULVIRA delivers a potent, targeted approach for hormone receptor positive advanced breast cancer, showing efficacy with uncommon reliability when administered correctly in clinical environments.